Press release
Dermatophytic Onychomycosis Therapeutics Market will surge to a market valuation of US$ 10.30 Bn by the end of 2031 | North America, Europe, APAC Region
Dermatophytic Onychomycosis Therapeutics Market
Additionally, the infection may spread to nearby skin. Although the illness is not thought to be life-threatening, it may pose physical and occupational constraints, which is why an increasing number of people are choosing to have their infected, thick, and cracked nails treated. The market for treatments for dermatophytic onychomycosis is consequently expanding.
Request for Free Sample Copy of Dermatophytic Onychomycosis Therapeutics Market @https://www.persistencemarketresearch.com/samples/5840
Tablets and nail paints, which are further divided into prescription (Rx) and over-the-counter, make up the tablet and nail paint segments of the global market for treatments for dermatophytic onychomycosis. The market for treatments for dermatophytic onychomycosis is anticipated to grow at a CAGR of 8.1% over the course of the forecast period, with the nail paint category projected to provide the largest share.
The global market for dermatophytic onychomycosis therapies has been divided into topical and oral treatment segments based on mode of administration. By 2026, the topical sector is expected to hold a about 70% share of the global market for treatments for dermatophytic onychomycosis, making it the dominating segment throughout the forecast period.
Increase in nail infection diagnoses has increased public knowledge of nail fungus infections and treatments for dermatophytic onychomycosis. In addition, dermatophytic onychomycosis therapies are becoming more widely known among podiatrists and dermatologists, which has increased demand for efficient drugs. However, side effects like headache, nausea, dizziness, and stomach discomfort linked to antifungal medications have made patients less confident about using a systemic therapy for nails.
Additionally, the topical medications also make the skin around the affected area rashy and itchy. The acceptability of dermatophytic onychomycosis treatments for the treatment of mild to severe dermatophytic onychomycosis linked with anti-fungal therapeutics is being hampered by these side effects.
Key Players in the Industry -
• Bausch Health
• Galderma S.A.
• Novartis AG
• Pfizer, Inc.
• Moberg Pharma AB
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Medimetriks Pharmaceuticals, Inc.
• Sanofi S.A.
• GlaxoSmithKline Plc.
• Teva Pharmaceutical industries Ltd.
• Cardinal Health Inc.
• Viatris Inc.
• Almirall, S.A
Request for report Customization@ https://www.persistencemarketresearch.com/request-customization/5840
Geographically, the market for therapies for dermatophytic onychomycosis is divided into five main areas: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).
Dermatophytic onychomycosis treatments were primarily sold in North America, and this tendency is anticipated to continue over the projected period. Therapeutics for dermatophytic onychomycosis are predicted to see the second-largest market share in Europe, after Asia Pacific.
Over the course of the forecast period, North America and Europe are anticipated to hold over 60% of the global market for treatments for dermatophytic onychomycosis.
Buy Now this Report @https://www.persistencemarketresearch.com/checkout/5840
Persistence market research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dermatophytic Onychomycosis Therapeutics Market will surge to a market valuation of US$ 10.30 Bn by the end of 2031 | North America, Europe, APAC Region here
News-ID: 2805334 • Views: …
More Releases from Persistence Market Research
Home Healthcare Market to Reach US$954.0 Bn by 2033 at 7.8% CAGR - Persistence M …
The global home healthcare market is undergoing a structural transformation as healthcare systems pivot toward decentralized, patient-centric care delivery models. The market is projected to expand from US$ 580.8 billion in 2026 to US$ 954.0 billion by 2033, registering a robust CAGR of 7.8% during the forecast period. This growth trajectory builds upon a historical CAGR of 6.2% recorded between 2020 and 2025, reflecting sustained momentum across both developed and…
U.S. Assisted Reproductive Technology Market Growth at 5.1% CAGR Through 2033 - …
The U.S. assisted reproductive technology (ART) market is entering a period of sustained expansion, driven by rising infertility rates, shifting family planning patterns, and rapid technological innovation. The market is projected to grow from US$10.5 billion in 2026 to US$14.8 billion by 2033, registering a compound annual growth rate (CAGR) of 5.1% during the forecast period. Historically, the industry recorded a CAGR of 4.4% between 2020 and 2025, reflecting steady…
Autologous Cell Therapy Market to Reach US$15.4Bn by 2033 at 12.6% CAGR - Persis …
The global autologous cell therapy market is entering a transformative phase, driven by accelerating advancements in regenerative medicine, rising chronic disease prevalence, and a growing emphasis on personalized healthcare. According to current projections, the market is expected to reach US$6.7 billion in 2026 and expand significantly to US$15.4 billion by 2033, registering a robust CAGR of 12.6% during the forecast period. Historically, between 2020 and 2025, the market grew at…
Command Hooks Market Expands with Surge in Renter-Friendly and Drill-Free Home D …
The global command hooks market is projected to grow from US$ 3.0 billion in 2026 to US$ 5.3 billion by 2033, at a CAGR of 8.1%, reflecting rising consumer demand for easy-to-install, damage-free home organization products. As modern households increasingly prioritize convenience, aesthetics, and flexibility, command hooks have emerged as essential tools for both residential and commercial applications. Their ability to provide reliable adhesion without drilling holes or damaging walls…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…
